Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 1

Results: 14

Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 1, doi. 10.1007/s00262-016-1909-3

By:

Ellmark, Peter;
Mangsbo, Sara;
Furebring, Christina;
Norlén, Per;
Tötterman, Thomas

Publication type:

Article

A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 25, doi. 10.1007/s00262-016-1913-7

By:

Chae, Young;
Chiec, Lauren;
Mohindra, Nisha;
Gentzler, Ryan;
Patel, Jyoti;
Giles, Francis

Publication type:

Article

Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 17, doi. 10.1007/s00262-016-1915-5

By:

Obara, Wataru;
Karashima, Takashi;
Takeda, Kazuyoshi;
Kato, Renpei;
Kato, Yoichiro;
Kanehira, Mitsugu;
Takata, Ryo;
Inoue, Keiji;
Katagiri, Toyomasa;
Shuin, Taro;
Nakamura, Yusuke;
Fujioka, Tomoaki

Publication type:

Article

Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 9, doi. 10.1007/s00262-016-1916-4

By:

Zloza, Andrew;
Dharmadhikari, Neal;
Huelsmann, Erica;
Broucek, Joseph;
Hughes, Tasha;
Kohlhapp, Frederick;
Kaufman, Howard

Publication type:

Article

Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 45, doi. 10.1007/s00262-016-1918-2

By:

Owonikoko, Taofeek;
Kumar, Mukesh;
Yang, Shu;
Kamphorst, Alice;
Pillai, Rathi;
Akondy, Rama;
Nautiyal, Vivek;
Chatwal, Monica;
Book, Wendy;
Sahu, Anurag;
Sica, Gabriel;
Ahmed, Rafi;
Ramalingam, Suresh

Publication type:

Article

High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 51, doi. 10.1007/s00262-016-1919-1

By:

Veluchamy, John;
Heeren, A.;
Spanholtz, Jan;
Eendenburg, Jaap;
Heideman, Daniëlle;
Kenter, Gemma;
Verheul, Henk;
Vliet, Hans;
Jordanova, Ekaterina;
Gruijl, Tanja

Publication type:

Article

Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 63, doi. 10.1007/s00262-016-1920-8

By:

Eby, Jonathan;
Barse, Levi;
Henning, Steven;
Rabelink, Martijn;
Klarquist, Jared;
Gilbert, Emily;
Hammer, Adam;
Fernandez, Manuel;
Yung, Nathan;
Khan, Safia;
Miller, Hannah;
Kessler, Edward;
Garrett-Mayer, Elizabeth;
Dilling, Daniel;
Hoeben, Rob;
Le Poole, I.

Publication type:

Article

Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 77, doi. 10.1007/s00262-016-1921-7

By:

Podaza, Enrique;
Sabbione, Florencia;
Risnik, Denise;
Borge, Mercedes;
Almejún, María;
Colado, Ana;
Fernández-Grecco, Horacio;
Cabrejo, María;
Bezares, Raimundo;
Trevani, Analía;
Gamberale, Romina;
Giordano, Mirta

Publication type:

Article

Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 91, doi. 10.1007/s00262-016-1922-6

By:

Winqvist, Maria;
Mozaffari, Fariba;
Palma, Marzia;
Eketorp Sylvan, Sandra;
Hansson, Lotta;
Mellstedt, Håkan;
Österborg, Anders;
Lundin, Jeanette

Publication type:

Article

Immunological effects of a novel RNA-based adjuvant in liver cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 103, doi. 10.1007/s00262-016-1923-5

By:

Circelli, Luisa;
Petrizzo, Annacarmen;
Tagliamonte, Maria;
Heidenreich, Regina;
Tornesello, Maria;
Buonaguro, Franco;
Buonaguro, Luigi

Publication type:

Article

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 119, doi. 10.1007/s00262-016-1925-3

By:

Sundara, Yayan;
Kostine, Marie;
Cleven, Arjen;
Bovée, Judith;
Schilham, Marco;
Cleton-Jansen, Anne-Marie

Publication type:

Article

Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 113, doi. 10.1007/s00262-016-1926-2

By:

Spain, Lavinia;
Walls, Gerard;
Messiou, Christina;
Turajlic, Samra;
Gore, Martin;
Larkin, James

Publication type:

Article

A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 129, doi. 10.1007/s00262-016-1927-1

By:

Herter, Sylvia;
Morra, Laura;
Schlenker, Ramona;
Sulcova, Jitka;
Fahrni, Linda;
Waldhauer, Inja;
Lehmann, Steffi;
Reisländer, Timo;
Agarkova, Irina;
Kelm, Jens;
Klein, Christian;
Umana, Pablo;
Bacac, Marina

Publication type:

Article

Heterogeneity of CD8 tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies.

Published in:

Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 33, doi. 10.1007/s00262-016-1908-4

By:

Obeid, Joseph;
Wages, Nolan;
Hu, Yinin;
Deacon, Donna;
Slingluff, Craig

Publication type:

Article